IMR Press / FBS / Volume 2 / Issue 1 / DOI: 10.2741/S59

Frontiers in Bioscience-Scholar (FBS) is published by IMR Press from Volume 13 Issue 1 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Novel therapeutic approaches in systemic lupus erythematosus
Show Less
1 National Institute of Rheumatology and Physiotherapy, Budapest, Hungary
2 Immunobiological Laboratory, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway

*Author to whom correspondence should be addressed.

Academic Editor: Arpad Barabas

Front. Biosci. (Schol Ed) 2010, 2(1), 221–228;
Published: 1 January 2010
(This article belongs to the Special Issue Autoimmune diseases: their etiology, pathogenesis and treatment)

Systemic lupus erythematosus is a prototypical systemic autoimmune disease, affecting multiple organs and organ-systems, leading to a wide variety of symptoms, serological and clinical features. The pathogenesis of the disease encompasses a complex interplay among various immune-competent cells and inflammatory mediators, which gives ground to target numerous potentially harmful players in this system. The aim of the present review was to depict certain aspects on the pathogenesis of SLE and to highlight pathways that can be promising targets of novel therapeutic approaches. T-cell, B-cell targeting, modification of co-stimulatory pathways, anti-cytokine therapy, soluble mediators, as well as autologous stem cell transplantation have been addressed. Finally, we described potential side effects of these biologics.

Back to top